Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma

Tanya Siddiqia City of Hope National Medical Center, Duarte, CA, USACorrespondence[email protected]
View further author information

Steven Coutreb Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA, USA

Paul M. Barrd Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA

Ahmad Mokatrinf Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information

Rudy Valentinof Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information

Anita Szokef Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information

Israel Arango-Hisijaraf Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information

Kojo Osei-Bonsuf Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information

Michael Wangh The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

Susan O’Brieni UC Irvine, Chao Family Comprehensive Cancer Center, Irvine, CA, USAView further author information

Your download is now in progress and you may close this window